NasdaqGM:ATRCMedical Equipment
A Look At AtriCure (ATRC) Valuation After Strong 2025 Earnings And Upbeat 2026 Outlook
AtriCure (ATRC) just reported fourth quarter and full year 2025 results that show higher sales and a shift to quarterly profitability, along with 2026 guidance that calls for revenue growth and positive full year net income.
See our latest analysis for AtriCure.
Even with the stronger quarterly results and 2026 guidance, AtriCure’s recent share price performance has been weak. The 30 day share price return shows a 16.25% decline and the 1 year total shareholder return reflects a 20.61% loss,...